HOOKIPA Pharma Inc (HOOK)
0.8598
+0.09
(+12.39%)
USD |
NASDAQ |
Apr 24, 16:00
0.821
-0.04
(-4.51%)
After-Hours: 20:00
HOOKIPA Pharma Cash from Investing (TTM): -4.159M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -4.159M |
September 30, 2023 | -4.336M |
June 30, 2023 | -2.276M |
March 31, 2023 | -3.463M |
December 31, 2022 | -5.017M |
September 30, 2022 | -9.559M |
June 30, 2022 | -11.09M |
March 31, 2022 | -14.08M |
December 31, 2021 | -12.58M |
September 30, 2021 | -7.945M |
June 30, 2021 | -6.084M |
Date | Value |
---|---|
March 31, 2021 | -2.502M |
December 31, 2020 | -2.371M |
September 30, 2020 | -2.912M |
June 30, 2020 | -2.649M |
March 31, 2020 | -1.798M |
December 31, 2019 | -1.999M |
September 30, 2019 | -1.203M |
June 30, 2019 | -1.121M |
March 31, 2019 | -2.288M |
December 31, 2018 | -2.15M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-14.08M
Minimum
Mar 2022
-1.121M
Maximum
Jun 2019
-5.113M
Average
-3.463M
Median
Mar 2023
Cash from Investing (TTM) Benchmarks
Gilead Sciences Inc | -2.265B |
Absci Corp | 81.94M |
NovaBay Pharmaceuticals Inc | -0.019M |
Palatin Technologies Inc | 9.293M |
iBio Inc | 8.285M |